Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07500545 · ClinicalTrials.gov registry record · NA
Community Health Adaptation & Resilience Mobilization (CHARM) HeatWise
A NA study, sponsored by Public Health Institute, California.
- Recruiting
- Registry status
- NA
- Development phase
- 580
- Enrollment target
NCT07500545: Recruiting NA study, sponsored by Public Health Institute, California.
NCT07500545 is a NA study that is actively recruiting participants, run by Public Health Institute, California. The registered enrollment target is 580 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07500545, a NA study, is actively recruiting participants, sponsored by Public Health Institute, California.
- RECRUITING
- Registry status
- NA
- Development phase
- 580 participants
- Enrollment target
Study Summary
Extreme heat events pose serious health risks, especially for communities with limited access to cooling, transportation, or social support. This study pilots and tests HEATwise, a heat preparedness program delivered at trusted community centers in Lake County, California, serving older adults, Tribal members, and people experiencing housing or economic hardship. HEATwise is a 12-week program which includes a group workshop on heat risks and preparedness, one-on-one resource navigation, a community celebration event, and a cooling and emergency supply kit. The pilot phase (2026) will assess feasibility and acceptability at three sites with approximately 60 participants. The full trial (2027-2028) will randomly assign eight sites to receive HEATwise immediately or after a delay, measuring whether the program increases protective behaviors, reduces heat-related symptoms, and strengthens resilience over 12 months.
Primary Outcome
Change in self-reported heat-illness symptoms: "Self-reported heat stress measure". Range 0-8, with higher scores indicating higher heat stress
Interventions
- BEHAVIORAL CHARM HeatWise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 580 participants |
| Start Date | 2026-04-15 |
| Est. Completion | 2028-06-02 |
| Phase | NA |
What NCT07500545 shows while recruiting
NCT07500545 is an interventional study that assigns participants to a tested intervention. The registered 580 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 1 intervention - of which CHARM HeatWise is the first listed.
NCT07500545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07500545 about?
NCT07500545 is a clinical study titled "Community Health Adaptation & Resilience Mobilization (CHARM) HeatWise". Extreme heat events pose serious health risks, especially for communities with limited access to cooling, transportation, or social support. This study pilots and tests HEATwise, a heat preparedness program delivered at trusted community centers in Lake County, California, serving older adults, Trib...
What is the current status of trial NCT07500545?
This trial is currently recruiting. It is a NA study. The enrollment target is 580 participants. The study started on 2026-04-15. Estimated completion is 2028-06-02.
What interventions are being tested in trial NCT07500545?
The interventions under investigation include: CHARM HeatWise (BEHAVIORAL).
Who is sponsoring clinical trial NCT07500545?
This trial is sponsored by Public Health Institute, California, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07500545's enrollment target sits among peer trials
580 177th of 2000 higher than 1,824 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
- NCT06578104 · 580 participants
PULSED AF Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI